Terug naar bedrijfspagina

Nieuws over argenx

30/10/2025 argenx - Reports Third Quarter 2025 Financial Results and Provides Business Update (30.10.2025)

28/08/2025 argenx - and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis News August 12, 2025 (28.08.2025)

08/08/2025 2025 06 - Dertiende kwartaal met groei

27/02/2025 argenx - to Report Full Year 2024 Financial Results and Fourth Quarter Business Update on February 27, 2025 (27.02.2025)

27/12/2024 argenx - Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (27.12.2024)

09/12/2024 2024 10 - Nu ook winstgevend

20/11/2024 argenx - Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies (20.11.2024)